Amgen has bought Five Prime Therapeutics for $1.9 Billion
Summary : Five Prime’s lead asset, Bemarituzumab, is a first-in-class, Phase 3 ready anti-FGFR2b antibody with positive data from a randomized, placebo-controlled…
Summary : Five Prime’s lead asset, Bemarituzumab, is a first-in-class, Phase 3 ready anti-FGFR2b antibody with positive data from a randomized, placebo-controlled…
Summary : Halozyme Therapeutics has announced a formal agreement to acquire all of Antares Pharma’s outstanding shares in a deal worth about…
Synopsis : Under the terms of the agreement, Pfizer will acquire ReViral for a total consideration of up to $525 million, including…
Synopsis : GlaxoSmithKline plc and Sierra Oncology, Inc have announced that GSK will acquire Sierra Oncology, a California-based late-stage biopharmaceutical company focused…
Summary : Food and Drug Administration on Apr 14 issued an emergency use authorization It said is the first device that can…
Summary: On February 8, 2022, the National Institute of Industrial Property (INPI) published a notice in Gazette 2666 detailing new rules for…
Summary : A federal jury has awarded biotechnology company Seagen Inc. $41.8 million in a patent infringement lawsuit against Daiichi Sankyo Co.…
New Agrochemical Discovery Candidates – New ISO Published in 2022 Spirobudifen (Acaricide) & Tiorantraniliprole (Diamide insecticides) April 2022 BCPC – Compendium of…
Summary : The U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol to…
Summary : The Australian Pesticides and Veterinary Administration (APVMA) has proposed approval of Bayer CropScience Pvt Ltd’s fungicide Xivana Prime 20 SC,…